Lensar (LNSR) EPS (Basic) Growth (3y) (2022 - 2026)
Lensar (LNSR) EPS (Basic) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 126.93 Bn | 123.46 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.34 Bn | 32.40 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.69 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 17.98% |
| 10 | Lensar | 102.43 Mn | 88.87 Mn | 9.78 Mn | 30.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.23% |
| Mar 31, 2026 | 80.71% |
| Dec 31, 2025 | 20.77% |
| Sep 30, 2025 | 7.56% |
| Jun 30, 2025 | 39.61% |
| Mar 31, 2025 | -51.37% |
| Dec 31, 2024 | -57.42% |
| Sep 30, 2024 | 41.67% |
| Jun 30, 2024 | -18.95% |
| Mar 31, 2024 | 30.49% |
| Dec 31, 2023 | 37.67% |
| Sep 30, 2023 | 30.10% |
| Jun 30, 2023 | 42.26% |
| Mar 31, 2023 | 51.27% |
| Dec 31, 2022 | 52.63% |
| Sep 30, 2022 | 58.44% |